Eton Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ETON and other ETFs, options, and stocks.

About ETON

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. 

CEO
Sean E. Brynjelsen
CEOSean E. Brynjelsen
Employees
44
Employees44
Headquarters
Deer Park, Illinois
HeadquartersDeer Park, Illinois
Founded
2017
Founded2017
Employees
44
Employees44

ETON Key Statistics

Market cap
1.60B
Market cap1.60B
Price-Earnings ratio
155.63
Price-Earnings ratio155.63
Dividend yield
Dividend yield
Average volume
644.45K
Average volume644.45K
High today
$59.85
High today$59.85
Low today
$50.11
Low today$50.11
Open price
$54.40
Open price$54.40
Volume
2.32M
Volume2.32M
52 Week high
$59.85
52 Week high$59.85
52 Week low
$14.27
52 Week low$14.27

Stock Snapshot

Eton Pharmaceuticals(ETON) stock is priced at $59.48, giving the company a market capitalization of 1.6B. It carries a P/E multiple of 155.63.

On 2026-08-17, Eton Pharmaceuticals(ETON) stock moved within a range of $50.11 to $59.85. With shares now at $59.48, the stock is trading +18.7% above its intraday low and -0.6% below the session's peak.

Trading volume for Eton Pharmaceuticals(ETON) stock has reached 2.32M, versus its average volume of 644.45K.

The stock's 52-week range extends from a low of $14.27 to a high of $59.85.

The stock's 52-week range extends from a low of $14.27 to a high of $59.85.

ETON News

The Motley Fool 3d
Why Eton Pharmaceuticals Is Top of the Class Today

Eton Pharmaceuticals (ETON +42.56%) stock soared 41.9% through 2:15 p.m. ET Friday after beating analyst forecasts for Q2 with a stick. Heading into the report,...

Why Eton Pharmaceuticals Is Top of the Class Today
Simply Wall St 4d
What Could Eton Pharmaceuticals Gain From The ASN 001 Licensing Deal?

Eton Pharmaceuticals (NasdaqGM: ETON) licensed U.S. rights to ASN-001, a potential first FDA-approved topical therapy for infantile hemangiomas, from Auson Phar...

What Could Eton Pharmaceuticals Gain From The ASN 001 Licensing Deal?

People also own

Based on the portfolios of people who own ETON. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.